SCHEMBL8006121

SCHEMBL8006121

Bc1cc(C(=O)O)cc(C(=O)OC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.50
CA12 O43570 4/20 0.50
CA1 P00915 4/20 0.50
CA2 P00918 4/20 0.50
CA7 P43166 4/20 0.50
CA9 Q16790 4/20 0.50
CA14 Q9ULX7 4/20 0.50
ALDH1A1 P00352 1/20 0.50
XDH P47989 2/20 0.48
LMNA P02545 2/20 0.48
POLB P06746 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
GAA P10253 1/20 0.48
NFKB1 P19838 1/20 0.48
GFER P55789 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
FUT7 Q11130 1/20 0.48
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8008793 0.92 CA1 (0.58) KDM4ECA12CA1CA2CA7
SCHEMBL9121827 0.89 CA12 (0.60) KDM4ECA12CA1CA2CA7
SCHEMBL7234945 0.89 CA12 (0.60) KDM4ECA12CA1CA2CA7
Methyl Alcohol SCHEMBL28269742 0.87 CA12 (0.58) KDM4ECA12CA1CA2CA7
SCHEMBL13761236 0.82 CA12 (0.50) KDM4ECA12CA1CA2CA7
SCHEMBL14301421 0.82 CA12 (0.52) KDM4ECA12CA1CA2CA7
SCHEMBL166126 0.82 TPMT (0.64) KDM4ECA12CA1CA2CA7
SCHEMBL17274803 0.82 CA12 (0.76) KDM4ECA12CA1CA2CA7
SCHEMBL1174380 0.82 CA12 (0.76) KDM4ECA12CA1CA2CA7
SCHEMBL31455886 0.82 CA12 (0.76) KDM4ECA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2196465-A1 (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors Almirall, S.A. (ES) 2010-06-16 EP disclosed
WO-2009110985-A2 AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF RENOVIS, INC. (US) 2009-09-11 WO disclosed